The Best Tech and Biotech Stocks

We scan the market for tech and biotech ideas and we add the best to our Orders queue, while we wait for an optimal entry point. Once those companies reach our price targets, we add them to our real-time Portfolio. New trades are accompanied by an audible chime and push notification (both optional) and blue highlighting.

The areas we cover include:

Biotechnology

Genomics and Synthetic Biology

Gene Editing

Cancer Therapeutics and Diagnostics

Regenerative Medicine

Pharmaceuticals

Reproductive Medicine

Technology

AI and Supercomputing

Robotics and Autonomous Vehicles

Virtual and Augmented Reality

Solar Energy

Nanotech, 3D Printing, and Material Science

Space and Aerospace

No Hype or Long Stories

Anyone who believes in exponential technological change respects that the value of time increases every day. We will NOT waste your time with long monthly essays hyping our latest stock pick. We also won’t pretend that we’ve uncovered secret knowledge that is not readily found in the public domain. We unearth the same story stocks promoted by our competitors and the few truly extraordinary ones are already in our Portfolio or on our internal watch list.

We offer your TIME back (and a break from the extravagant claims) by providing brief comments for each of our Portfolio positions. For our subscribers that enjoy learning the deeper back-stories to our picks, we provide links to our favorite outside experts and writers, so you can read as much or as little as you wish.

FundamentalandTechnical Analysis

What truly separates our service from the pack is our focus on technical analysis. While fundamentals are the basis for our initial interest, technicals are what inform our buying and selling decisions. Developed and refined over years, our proprietary technical methods let us know when we can buy with maximum safety or sell after taking maximum gains. We won’t talk much about it, as our methods are unique and proprietary, but our performance should speak for itself…

Performance Tracking

How many newsletters tout their biggest winners but do not disclose their total portfolio performance? The answer is virtually all. If their total performance is good, why do they omit it from their marketing? While that kind of spin may get them greater sales, we feel it is misleading at best.

Low Cost

Comparable services charge $2000-$5000 annually. We charge dramatically less at $99 per month or $949 per year (20% savings).

[easy-pricing-table id=”2429″]

Our subscription prices are set to rise in the near future as we add new custom features. Lock in your low promotional price now and your subscription will automatically renew at current levels for as long as the subscription is maintained.